Daily

#JPM15 Buzz: BIG deals, and a bobblehead

The eve of JP Morgan healthcare investment conference’s launch was marked by binge drinking, a number of big deals – and the bobblehead doppelgänger of TheStreet’s Adam Feuerstein, who shant be at this year’s conference. With huge news from Shire, Alnylam, Roche and others, here are some of the top tweets from the  #JPM15 Twitterverse that outline all the […]

The eve of JP Morgan healthcare investment conference’s launch was marked by binge drinking, a number of big deals – and the bobblehead doppelgänger of TheStreet’s Adam Feuerstein, who shant be at this year’s conference.

With huge news from Shire, Alnylam, Roche and others, here are some of the top tweets from the  #JPM15 Twitterverse that outline all the latest:

presented by

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.